NEW MEDICAL TECHNOLOGIES IN THE TREATMENT OF CHRONIC FORMS OF HEADACHE
The frequency, duration, and intensity of headache were reduced after treatment of chronic daily headache (CDH) with botulinum toxin type A (Lantox). Extravasal effect on cerebral blood flow was not found in 34% of patients; it became moderate in 66%; normalization of venous return from the head cavity was noted in 58%; pronounced changes remained only in 10% of the patients treated with Lantox, as confirmed by its use for CDH.